| Thermostable DNA polymerase chain amplification of t (14; 18) chromosome breakpoints and detection of minimal residual disease. M Crescenzi, M Seto, GP Herzig, PD Weiss, RC Griffith, SJ Korsmeyer Proceedings of the National Academy of Sciences 85 (13), 4869-4873, 1988 | 402 | 1988 |
| New functions of XPC in the protection of human skin cells from oxidative damage M d'Errico, E Parlanti, M Teson, BMB de Jesus, P Degan, A Calcagnile, ... The EMBO journal 25 (18), 4305-4315, 2006 | 293 | 2006 |
| The mammalian mismatch repair pathway removes DNA 8-oxodGMP incorporated from the oxidized dNTP pool C Colussi, E Parlanti, P Degan, G Aquilina, D Barnes, P Macpherson, ... Current biology 12 (11), 912-918, 2002 | 285 | 2002 |
| MyoD induces growth arrest independent of differentiation in normal and transformed cells. M Crescenzi, TP Fleming, AB Lassar, H Weintraub, SA Aaronson Proceedings of the National Academy of Sciences 87 (21), 8442-8446, 1990 | 266 | 1990 |
| α6β4 and α6β1 integrins associate with ErbB-2 in human carcinoma cell lines R Falcioni, A Antonini, P Nisticò, S Di Stefano, M Crescenzi, PG Natali, ... Experimental cell research 236 (1), 76-85, 1997 | 265 | 1997 |
| Human MRE11 is inactivated in mismatch repair‐deficient cancers G Giannini, E Ristori, F Cerignoli, C Rinaldi, M Zani, A Viel, L Ottini, ... EMBO reports, 2002 | 213 | 2002 |
| High efficiency myogenic conversion of human fibroblasts by adenoviral vector-mediated MyoD gene transfer. An alternative strategy for ex vivo gene therapy of primary myopathies. L Lattanzi, G Salvatori, M Coletta, C Sonnino, MGC De Angelis, L Gioglio, ... The Journal of clinical investigation 101 (10), 2119-2128, 1998 | 206 | 1998 |
| p53 re-expression inhibits proliferation and restores differentiation of human thyroid anaplastic carcinoma cells F Moretti, A Farsetti, S Soddu, S Misiti, M Crescenzi, S Filetti, M Andreoli, ... Oncogene 14 (6), 729-740, 1997 | 199 | 1997 |
| Development of a highly efficient expression cDNA cloning system: application to oncogene isolation. T Miki, TP Fleming, M Crescenzi, CJ Molloy, SB Blam, SH Reynolds, ... Proceedings of the National Academy of Sciences 88 (12), 5167-5171, 1991 | 176 | 1991 |
| Interference with p53 protein inhibits hematopoietic and muscle differentiation. S Soddu, G Blandino, R Scardigli, S Coen, A Marchetti, MG Rizzo, ... Journal of Cell Biology 134 (1), 193-204, 1996 | 167 | 1996 |
| Inhibition of ErbB-2 mitogenic and transforming activity by RALT, a mitogen-induced signal transducer which binds to the ErbB-2 kinase domain L Fiorentino, C Pertica, M Fiorini, C Talora, M Crescenzi, L Castellani, ... Molecular and cellular biology 20 (20), 7735-7750, 2000 | 166 | 2000 |
| Che-1 phosphorylation by ATM/ATR and Chk2 kinases activates p53 transcription and the G2/M checkpoint T Bruno, F De Nicola, S Iezzi, D Lecis, C D'Angelo, M Di Padova, N Corbi, ... Cancer cell 10 (6), 473-486, 2006 | 149 | 2006 |
| Terminally differentiated muscle cells are defective in base excision DNA repair and hypersensitive to oxygen injury L Narciso, P Fortini, D Pajalunga, A Franchitto, P Liu, P Degan, M Frechet, ... Proceedings of the National Academy of Sciences 104 (43), 17010-17015, 2007 | 142 | 2007 |
| Programmed cell death 4 and micro RNA 21 inverse expression is maintained in cells and exosomes from ovarian serous carcinoma effusions R Cappellesso, A Tinazzi, T Giurici, F Simonato, V Guzzardo, L Ventura, ... Cancer cytopathology 122 (9), 685-693, 2014 | 130 | 2014 |
| The mammalian mismatch repair protein MSH2 is required for correct MRE11 and RAD51 relocalization and for efficient cell cycle arrest induced by ionizing radiation in G2 phase A Franchitto, P Pichierri, R Piergentili, M Crescenzi, M Bignami, F Palitti Oncogene 22 (14), 2110-2120, 2003 | 126 | 2003 |
| Anti-angiogenic gene therapy of cancer: current status and future prospects L Persano, M Crescenzi, S Indraccolo Molecular aspects of medicine 28 (1), 87-114, 2007 | 125 | 2007 |
| Np95 is regulated by E1A during mitotic reactivation of terminally differentiated cells and is essential for S phase entry IM Bonapace, L Latella, R Papait, F Nicassio, A Sacco, M Muto, ... Journal of Cell Biology 157 (6), 909-914, 2002 | 115 | 2002 |
| Knockdown of cyclin-dependent kinase inhibitors induces cardiomyocyte re-entry in the cell cycle V Di Stefano, M Giacca, MC Capogrossi, M Crescenzi, F Martelli Journal of Biological Chemistry 286 (10), 8644-8654, 2011 | 114 | 2011 |
| Reconstitution of cyclin D1-associated kinase activity drives terminally differentiated cells into the cell cycle L Latella, A Sacco, D Pajalunga, M Tiainen, D Macera, M D'Angelo, ... Molecular and Cellular Biology 21 (16), 5631-5643, 2001 | 108 | 2001 |
| Critical requirement for cell cycle inhibitors in sustaining nonproliferative states D Pajalunga, A Mazzola, AM Salzano, MG Biferi, G De Luca, M Crescenzi The Journal of cell biology 176 (6), 807-818, 2007 | 105 | 2007 |
Alessandro GiulianiIstituto Superiore di SanitàVerified email at iss.it
